Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Multiple myeloma, gammopathies

Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: The outcome of a range of molecular and clinical features as a function of age.
Fig. 2: The distribution and nature of the mutations used to define clonal hematopoiesis.

References

  1. 1.

    Myeloma - Cancer Stat Facts. SEER. https://seer.cancer.gov/statfacts/html/mulmy.html. Accessed 7 Aug 2020.

  2. 2.

    Ageing Europe—2019 edition. https://ec.europa.eu/eurostat/web/products-statistical-books/-/KS-02-19-681. Accessed 7 Aug 2020.

  3. 3.

    Population Projections. https://www.census.gov/programs-surveys/popproj.html. Accessed 7 Aug 2020.

  4. 4.

    Home—Office for National Statistics. https://www.ons.gov.uk/. Accessed 7 Aug 2020.

  5. 5.

    Mouhieddine TH, Sperling AS, Redd R, Park J, Leventhal M, Gibson CJ, et al. Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. Nat Commun. 2020;11:2996.

    CAS  Article  Google Scholar 

  6. 6.

    Rustad EH, Yellapantula V, Leongamornlert D, Bolli N, Ledergor G, Nadeu F, et al. Timing the initiation of multiple myeloma. Nat Commun. 2020;11:1917.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We thank all the patients and their families for their contributions to this study. The authors acknowledge continued support from Multiple Myeloma Research Foundation and the Perelman Family Foundation. BAW and GJM received grant support through a Translational Research Program award from the Leukemia & Lymphoma Society (6020-20). EMB received funding from the Fédération Française de Recherche sur le Myélome et les Gammapathies under the aegis of the Fondation de France.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Gareth J. Morgan.

Ethics declarations

Competing interests

The authors declare no competing interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Boyle, E.M., Williams, L., Blaney, P. et al. Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length. Leukemia (2021). https://doi.org/10.1038/s41375-021-01320-3

Download citation

Search

Quick links